Neogen Chemicals Ltd. (IN:NEOGEN)
:NEOGEN
NEOGEN Stock Chart & Stats
₹1156.90
₹9.65(0.45%)
At close: 4:00 PM EST
₹1156.90
₹9.65(0.45%)
Day’s Range― - ―
52-Week Range₹978.00 - ₹1,788.00
Previous CloseN/A
Volume22.32K
Average Volume (3M)9.36K
Market Cap
₹31.68B
Enterprise Value₹42.58B
Total Cash (Recent Filing)₹5.00B
Total Debt (Recent Filing)₹11.32B
Price to Earnings (P/E)211.5
Beta1.39
Next Earnings
May 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.09%
Share Statistics
EPS (TTM)1.40
Shares Outstanding26,381,674
10 Day Avg. Volume1,157
30 Day Avg. Volume9,357
Financial Highlights & Ratios
PEG Ratio-22.51
Price to Book (P/B)5.41
Price to Sales (P/S)5.49
P/FCF Ratio-35.07
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹2,001.00Price Target Upside72.96% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)26.38
Revenue Forecast (FY)₹13.45B
Bulls Say, Bears Say
Bulls Say
Revenue And Margin ImprovementSustained revenue growth and improving EBIT/EBITDA margins indicate durable operational improvement and scaling of higher-margin specialty products. Over a 2–6 month horizon this supports reinvestment capacity and operational leverage, underpinning long-term profitability if net margin pressures are managed.
Specialty Product Exposure Across Durable End MarketsA product mix centered on bromine and lithium intermediates supplies pharma, agrochemicals and energy-storage supply chains. These sectors offer structural demand and higher technical barriers to entry, supporting steady order flow and pricing power over months and reducing exposure to commoditized cyclicality.
Growing Equity BaseA steadily increasing equity base provides a capital buffer for expansions or cyclical stress and reduces immediate dilution needs. This strengthens credit standing and gives the company optionality for capex or strategic investments over the medium term despite other balance-sheet constraints.
Bears Say
Relatively High LeverageMaterial leverage raises interest and refinancing risk and can constrain capital allocation choices. Over 2–6 months rising rates or weaker cash flow could pressure liquidity, elevate financing costs, and limit the firm's ability to invest in capacity or absorb demand shocks without raising external capital.
Volatile Cash Generation And Negative Free Cash FlowInconsistent cash conversion and recent negative free cash flow reduce internal funding for working capital and growth. This forces reliance on external financing or equity, increasing funding risk and potentially delaying strategic investments or margin improvement initiatives over the medium term.
Low Net Margins And Weak EPS GrowthLow net margins imply limited retained profit from revenue growth, while steep EPS decline signals earnings volatility or one-off pressures. Persistently weak bottom-line conversion undermines free cash flow and shareholder returns, constraining the sustainability of growth investments and long-term profitability.
Neogen Chemicals Ltd. News
NEOGEN FAQ
What was Neogen Chemicals Ltd.’s price range in the past 12 months?
Neogen Chemicals Ltd. lowest stock price was ₹978.00 and its highest was ₹1788.00 in the past 12 months.
What is Neogen Chemicals Ltd.’s market cap?
Neogen Chemicals Ltd.’s market cap is ₹31.68B.
When is Neogen Chemicals Ltd.’s upcoming earnings report date?
Neogen Chemicals Ltd.’s upcoming earnings report date is May 25, 2026 which is in 49 days.
How were Neogen Chemicals Ltd.’s earnings last quarter?
Neogen Chemicals Ltd. released its earnings results on Feb 11, 2026. The company reported ₹1.4 earnings per share for the quarter, missing the consensus estimate of ₹2.733 by -₹1.333.
Is Neogen Chemicals Ltd. overvalued?
According to Wall Street analysts Neogen Chemicals Ltd.’s price is currently Undervalued.
Does Neogen Chemicals Ltd. pay dividends?
Neogen Chemicals Ltd. pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.09%. See more information on Neogen Chemicals Ltd. dividends here
What is Neogen Chemicals Ltd.’s EPS estimate?
Neogen Chemicals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Neogen Chemicals Ltd. have?
Neogen Chemicals Ltd. has 26,381,674 shares outstanding.
What happened to Neogen Chemicals Ltd.’s price movement after its last earnings report?
Neogen Chemicals Ltd. reported an EPS of ₹1.4 in its last earnings report, missing expectations of ₹2.733. Following the earnings report the stock price went down -0.898%.
Which hedge fund is a major shareholder of Neogen Chemicals Ltd.?
Currently, no hedge funds are holding shares in IN:NEOGEN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Neogen Chemicals Ltd.
Neogen Chemicals Limited manufactures and sells specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds, unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; inorganic bromine compounds and lithium salts; grignard reagents; and advance intermediates. The company also provides custom synthesis and manufacturing services. It serves pharmaceutical, agrochemical, engineering, flavour and fragrance, electronic-chemical, refrigeration, construction chemicals, pharmaceutical, and specialty polymer industries, as well as heating, ventilation, and air-conditioning industries. The company also exports its products to 28 countries. Neogen Chemicals Limited was incorporated in 1989 and is based in Thane, India.
NEOGEN Stock 12 Month Forecast
Average Price Target
₹2,001.00
▲(72.96% Upside)
Technical Analysis
Balaji Amines Limited
―
Hikal Limited
―
Rossari Biotech Ltd
―
Thirumalai Chemicals Limited
―
UFlex Limited
―